The above results suggested that LMP1 augmented Igκ intron enhancer activity, which in turn facilitated the expression upregulation of Igκ via NF-κB and AP-1 signaling pathways in NPC cells [55]. The gene discussed is PDLIM7; the disease is nasopharyngeal carcinoma.